Medicine
Carisoprodol 350 mg tablet
Carisoprodol 350 mg tablet is a generic prescription medicine for oral use, made by 24 labelers, with its source record on the US FDA register. It is available on request for export supply from India to licensed hospitals, importers and physicians.
Availability
Export supply from India to licensed buyers
Typical lead time
On request
Counted from payment and complete documents
Shipping
Ambient
Store at controlled room temperature 20° - 25°C (68° - 77°F).
Key facts
- Active ingredient (INN)
- Carisoprodol
- Brand
- Sold under the generic name
- Strength
- 350 mg
- Dosage form
- Tablet
- Route
- Oral
- Packs
- 100 tablets, 500 tablets, 1000 tablets and 129 more
- Manufacturers
- Aurobindo PharmaIndiaBryant Ranch PrepackScieGen PharmaceuticalsOxford PharmaceuticalsRising Pharma HoldingsVensun PharmaceuticalsGranulation TechnologyIngenus PharmaceuticalsChartwell RXWilshire Pharmaceuticals24 labelers on the register
- Origin register
- US FDA, United States
- Storage
- Store at controlled room temperature 20° - 25°C (68° - 77°F).
- Cold chain
- Not required on record
- Prescription status
- Prescription only
- Controlled substance
- Schedule CIV
- ATC code
- M03BA02 Carisoprodol
- HS code (indicative)
- 3004.90Indicative only. Your customs broker confirms the final tariff code.
- Marketing category
- marketed
- Marketed since
- 6 August 2009
- Identifiers
- RxCUI 197446, 730794DailyMed set ID 2484de44-b36a-421c-a4d9-64c201694754, 8e9bb49a-8cc3-4390-e053-2a95a90a4e0e, acc7f959-55ac-4d9b-8ef4-4538378364e6 +37NDC 71610-761, 61919-878, 63629-2416 +37Application ANDA040188, ANDA203374, ANDA040792 +5
Record updated 12 November 2026
Documents available
Documents that can be provided with this medicine. Your regulator may ask for more, and the quote lists the full set.
No document list is recorded for this medicine yet. Tell us which documents your regulator needs (for example a CoA, COPP or GMP certificate) when you request a quote.
Packs
A sample of 40 packs from 24 labelers. The register lists 132 packs for this generic presentation, and we confirm the exact pack on the quote.
| Pack | Code | Labeler | Marketed since |
|---|---|---|---|
| 100 tablet in 1 bottle | 65862-158-01 | Aurobindo PharmaIndia | 6 August 2009 |
| 500 tablet in 1 bottle | 65862-158-05 | Aurobindo PharmaIndia | 6 August 2009 |
| 1000 tablet in 1 bottle | 65862-158-99 | Aurobindo PharmaIndia | 6 August 2009 |
| 120 tablet in 1 bottle | 62135-241-12 | Chartwell RX | 5 January 2023 |
| 100 tablet in 1 bottle, plastic | 63561-0127-1 | Granulation Technology | 11 June 2025 |
| 1000 tablet in 1 bottle, plastic | 63561-0127-2 | Granulation Technology | 11 June 2025 |
| 100 tablet in 1 bottle | 50742-656-01 | Ingenus Pharmaceuticals | 21 May 2019 |
| 500 tablet in 1 bottle | 50742-656-05 | Ingenus Pharmaceuticals | 21 May 2019 |
| 100 tablet in 1 bottle | 69584-111-10 | Oxford Pharmaceuticals | 20 January 2020 |
| 500 tablet in 1 bottle | 69584-111-50 | Oxford Pharmaceuticals | 20 January 2020 |
| 1000 tablet in 1 bottle | 69584-111-90 | Oxford Pharmaceuticals | 20 January 2020 |
| 100 tablet in 1 bottle | 16571-781-01 | Rising Pharma Holdings | 6 August 2009 |
| 1000 tablet in 1 bottle | 16571-781-10 | Rising Pharma Holdings | 6 August 2009 |
| 500 tablet in 1 bottle | 16571-781-50 | Rising Pharma Holdings | 6 August 2009 |
| 100 tablet in 1 bottle | 50228-109-01 | ScieGen Pharmaceuticals | 27 January 2014 |
| 500 tablet in 1 bottle | 50228-109-05 | ScieGen Pharmaceuticals | 27 January 2014 |
| 1000 tablet in 1 bottle | 50228-109-10 | ScieGen Pharmaceuticals | 27 January 2014 |
| 30 tablet in 1 bottle | 50228-109-30 | ScieGen Pharmaceuticals | 27 January 2014 |
| 100 tablet in 1 bottle | 42543-700-01 | Vensun Pharmaceuticals | 31 July 2014 |
| 500 tablet in 1 bottle | 42543-700-05 | Vensun Pharmaceuticals | 31 July 2014 |
| 1000 tablet in 1 bottle | 42543-700-10 | Vensun Pharmaceuticals | 31 July 2014 |
| 100 tablet in 1 bottle | 52536-688-10 | Wilshire Pharmaceuticals | 15 February 2017 |
| 100 tablet in 1 bottle | 63629-2416-1 | Bryant Ranch Prepack | 20 January 2020 |
| 1000 tablet in 1 bottle | 63629-8477-1 | Bryant Ranch Prepack | 18 May 2021 |
| 500 tablet in 1 bottle | 63629-8478-1 | Bryant Ranch Prepack | 18 May 2021 |
| 100 tablet in 1 bottle | 63629-8479-1 | Bryant Ranch Prepack | 18 May 2021 |
| 56 tablet in 1 bottle | 71335-1203-0 | Bryant Ranch Prepack | 28 December 2021 |
| 14 tablet in 1 bottle | 71335-1203-1 | Bryant Ranch Prepack | 10 May 2019 |
| 28 tablet in 1 bottle | 71335-1203-2 | Bryant Ranch Prepack | 28 December 2021 |
| 60 tablet in 1 bottle | 71335-1203-3 | Bryant Ranch Prepack | 25 April 2019 |
| 20 tablet in 1 bottle | 71335-1203-4 | Bryant Ranch Prepack | 17 May 2019 |
| 30 tablet in 1 bottle | 71335-1203-5 | Bryant Ranch Prepack | 17 May 2019 |
| 84 tablet in 1 bottle | 71335-1203-6 | Bryant Ranch Prepack | 28 December 2021 |
| 90 tablet in 1 bottle | 71335-1203-7 | Bryant Ranch Prepack | 20 May 2019 |
| 100 tablet in 1 bottle | 71335-1203-8 | Bryant Ranch Prepack | 28 December 2021 |
| 120 tablet in 1 bottle | 71335-1203-9 | Bryant Ranch Prepack | 6 May 2019 |
| 1000 tablet in 1 bottle | 71335-3018-1 | Bryant Ranch Prepack | 3 December 2025 |
| 56 tablet in 1 bottle | 71335-9613-0 | Bryant Ranch Prepack | 3 April 2024 |
| 14 tablet in 1 bottle | 71335-9613-1 | Bryant Ranch Prepack | 1 March 2024 |
| 28 tablet in 1 bottle | 71335-9613-2 | Bryant Ranch Prepack | 3 April 2024 |
Status by register
Where this medicine is registered, from the source record and the regulator data we hold. Ask us about a country that is not listed.
| Register | Status | Source |
|---|---|---|
| US FDA | Listed, marketed | Source record for this pageChecked 12 November 2026 |
| US FDA | First approved 9 April 1959 | Drugs@FDA |
| EU (EMA) | Not recorded | — |
| India (CDSCO) | Not yet confirmed against CDSCO approval lists | — |
| United States | Registered | US FDA (NDC directory, openFDA)Checked 12 November 2026 |
Import route
Pick the destination country to see the legal import route, who applies and typical timelines, from our import guide for that country.
Import guides are available for 25 countries. Pick one to see its route summary.
BrazilColombiaEgyptEthiopiaGhanaIraqKazakhstanKenyaAll import guides
Alternatives
Other makers and brands of Carisoprodol 350 mg tablet.
Other strengths and forms of Carisoprodol
Clinical summary
Carisoprodol is a muscle relaxant indicated for the relief of discomfort associated with acute, painful musculoskeletal conditions in adults. It is available as tablets for oral use. MedsAcross supplies Carisoprodol for export from India to licensed hospitals, importers and physicians acting for named patients, with the documents each country requires.
Information from the US FDA prescribing information, retrieved 12 November 2026. Not yet medically reviewed.How we review
Read about CarisoprodolFor healthcare professionals and buyers. This is not medical advice. Treatment decisions belong to the prescriber.
Data sources
- DailyMed label record · Checked 12 November 2026
- Soma prescribing information (Viatris Specialty) · U.S. National Library of Medicine, DailyMed
Need Carisoprodol 350 mg tablet for your hospital or patient?
Send one request with the destination country and quantity. We confirm availability, lead time and the documents your regulator needs.